{"id":18014,"date":"2016-07-05T16:12:26","date_gmt":"2016-07-05T20:12:26","guid":{"rendered":"http:\/\/www.healthynewbornnetwork.org\/?post_type=resource&#038;p=18014"},"modified":"2022-09-26T17:50:34","modified_gmt":"2022-09-26T21:50:34","slug":"chlorhexidine-performance-indicators","status":"publish","type":"resource","link":"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/","title":{"rendered":"Chlorhexidine Performance Indicators"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":7211,"featured_media":18016,"comment_status":"open","ping_status":"closed","template":"","toolkit":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Healthy Newborn Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chlorhexidine Performance Indicators - Healthy Newborn Network\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/\" \/>\n<meta property=\"og:site_name\" content=\"Healthy Newborn Network\" \/>\n<meta property=\"article:modified_time\" content=\"2022-09-26T21:50:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Thumbnail-for-HNN-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"689\" \/>\n\t<meta property=\"og:image:height\" content=\"888\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/\",\"url\":\"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/\",\"name\":\"Chlorhexidine Performance Indicators - Healthy Newborn Network\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthynewbornnetwork.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Thumbnail-for-HNN-1.jpg\",\"datePublished\":\"2016-07-05T20:12:26+00:00\",\"dateModified\":\"2022-09-26T21:50:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/#primaryimage\",\"url\":\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Thumbnail-for-HNN-1.jpg\",\"contentUrl\":\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Thumbnail-for-HNN-1.jpg\",\"width\":689,\"height\":888},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthynewbornnetwork.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Chlorhexidine Performance Indicators\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthynewbornnetwork.org\/#website\",\"url\":\"https:\/\/www.healthynewbornnetwork.org\/\",\"name\":\"Healthy Newborn Network\",\"description\":\"Addressing critical knowledge gaps in newborn health.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthynewbornnetwork.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Healthy Newborn Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/","og_locale":"en_US","og_type":"article","og_title":"Chlorhexidine Performance Indicators - Healthy Newborn Network","og_url":"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/","og_site_name":"Healthy Newborn Network","article_modified_time":"2022-09-26T21:50:34+00:00","og_image":[{"width":689,"height":888,"url":"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Thumbnail-for-HNN-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/","url":"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/","name":"Chlorhexidine Performance Indicators - Healthy Newborn Network","isPartOf":{"@id":"https:\/\/www.healthynewbornnetwork.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/#primaryimage"},"image":{"@id":"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/#primaryimage"},"thumbnailUrl":"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Thumbnail-for-HNN-1.jpg","datePublished":"2016-07-05T20:12:26+00:00","dateModified":"2022-09-26T21:50:34+00:00","breadcrumb":{"@id":"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/#primaryimage","url":"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Thumbnail-for-HNN-1.jpg","contentUrl":"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Thumbnail-for-HNN-1.jpg","width":689,"height":888},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-performance-indicators\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthynewbornnetwork.org\/"},{"@type":"ListItem","position":2,"name":"Chlorhexidine Performance Indicators"}]},{"@type":"WebSite","@id":"https:\/\/www.healthynewbornnetwork.org\/#website","url":"https:\/\/www.healthynewbornnetwork.org\/","name":"Healthy Newborn Network","description":"Addressing critical knowledge gaps in newborn health.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthynewbornnetwork.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"featured_image":"<img width=\"689\" height=\"888\" src=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Thumbnail-for-HNN-1.jpg\" class=\"attachment-medium_large size-medium_large\" alt=\"\" decoding=\"async\" srcset=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Thumbnail-for-HNN-1.jpg 689w, https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Thumbnail-for-HNN-1-233x300.jpg 233w\" sizes=\"(max-width: 689px) 100vw, 689px\" \/>","author_name":"HNN Team","author_image":"<img src=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/themes\/hnn\/dist\/images\/member-default.jpg\" alt=\"\" class=\"avatar avatar-32 photo\" height=\"32\" width=\"32\"\/>","acf_custom_fields":{"publication_date":"20160705","authors":false,"additional_authors":"Chlorhexidine Working Group","type":"tools_guidelines","language":["en"],"external_links":[{"link":""}],"files":[{"file":"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Performance-Indicators-CHX.pdf"}],"partners":[],"other_organizations":"","issues":[{"ID":118,"post_author":"7211","post_date":"2015-10-21 15:18:04","post_date_gmt":"2015-10-21 19:18:04","post_content":"[vc_row][vc_column][vc_column_text]\r\n<h2 style=\"text-align: center;\"><em>As of 2022, the below information reflects outdated global consensus and guidance. For up-to-date guidance on umbilical cord care, including chlorhexidine, please visit the <a href=\"https:\/\/www.healthynewbornnetwork.org\/issue\/umbilical-cord-care\/\">Umbilical Cord Care page<\/a>.<\/em><\/h2>\r\n[\/vc_column_text][vc_btn title=\"Umbilical Cord Care\" color=\"1\" size=\"lg\" align=\"center\" button_block=\"true\" link=\"url:https%3A%2F%2Fwww.healthynewbornnetwork.org%2Fissue%2Fumbilical-cord-care%2F|title:Umbilical%20cord%20care\"][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator][vc_column_text]\r\n<h2><strong><a href=\"#getready\">Get Ready\u00a0\u00a0\u00a0<\/a><\/strong>|\u00a0 \u00a0<strong><a href=\"#plan\">Plan\u00a0<\/a><\/strong>\u00a0 |\u00a0 \u00a0<strong><a href=\"#execute\">Execute\u00a0\u00a0<\/a><\/strong>\u00a0|\u00a0 \u00a0<strong><a href=\"#about\">About\u00a0\u00a0\u00a0\u00a0<\/a><\/strong>|\u00a0 \u00a0<strong><a href=\"#country\">Country Specific Resources<\/a><\/strong><\/h2>\r\n<h2><\/h2>\r\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=\"stretch_row\" css=\".vc_custom_1453403441710{margin-top: -60px !important;padding-top: 30px !important;padding-bottom: 30px !important;background-color: #ffffff !important;}\"][vc_column width=\"1\/2\"][vc_column_text]\r\n<h2 style=\"text-align: justify;\">Ensuring optimal cord care at birth and during the first week of life, including use of chlorhexidine, especially in settings having poor hygiene, is a crucial strategy to prevent life-threatening sepsis and cord infections and avert preventable neonatal deaths.<\/h2>\r\n<p style=\"text-align: justify;\">Chlorhexidine digluconate is a broad spectrum antiseptic that is available in a range of concentrations and has been safely used for over 40 years for a variety of health-related applications; but its specific use for umbilical cord care was uniquely tested in three clinical trials in Nepal, Bangladesh, and Pakistan, in the form of 7.1% chlorhexidine digluconate (CHX). Given the promising results of the trials, in 2013 the World Health Organization (WHO) added CHX to its <a href=\"http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/\" target=\"_blank\" rel=\"noopener noreferrer\">Model List of Essential Medicines for Children<\/a>; and in 2014 the WHO issued a new <a href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/97603\/1\/9789241506649_eng.pdf?ua=1\" target=\"_blank\" rel=\"noopener noreferrer\">guideline<\/a> on umbilical cord care, which included a formal recommendation on the use of chlorhexidine.<\/p>\r\n[\/vc_column_text][vc_column_text]\r\n<p style=\"text-align: justify;\">This webpage was developed by the <a href=\"#about\">Chlorhexidine Working Group<\/a>\u00a0(CWG) to help policy makers, program managers, and donors facilitate the introduction of 7.1% chlorhexidine digluconate into existing essential newborn care services in low- and middle-income countries. The document, <a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/CHXstory_From-Research-to-Use_01.22.18.pdf\">From Research to Use: Saving Newborn Lives with Chlorhexidine for Umbilical Cord Care<\/a> chronicles the history and accomplishments of the CWG. The webpage consists of three phases, <strong><a href=\"#getready\">Get Ready<\/a><\/strong>, <strong><a href=\"#plan\">Plan<\/a><\/strong>, and <strong><a href=\"#execute\">Execute<\/a><\/strong>, and is based on the experiences of the CWG partners in introducing chlorhexidine in various countries (see <a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/guide-implementing-7-1-chlorhexidine-digluconate-umbilical-cord-care\/\">Guide to Implementing 7.1% chlorhexidine digluconate for umbilical cord care: Three phases to ensure sustainable implementation<\/a>). Each phase\u00a0is composed of activities that facilitate introduction and scale-up. The phases do not necessarily occur in a sequential manner; however, as some activities\/components across the three phases may\u00a0occur simultaneously while others are dependent upon the results of activities from a previous phase.<\/p>\r\n[\/vc_column_text][\/vc_column][vc_column width=\"1\/2\" el_class=\"issue-stats\"][vc_cta h2=\"Chlorhexidine Global Scale-Up Tracker\" style=\"outline\" color=\"sandy-brown\" css=\".vc_custom_1503604990256{border-radius: 5px !important;}\"]\r\n\r\n[caption id=\"attachment_17423\" align=\"alignright\" width=\"250\"]<a href=\"https:\/\/www.healthynewbornnetwork.org\/chlorhexidine-dashboard\/\"><img class=\"wp-image-17423\" src=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Dashboard-Thumbnail-1-300x211.jpg\" alt=\"Dashboard Thumbnail\" width=\"250\" height=\"176\" \/><\/a> Click on the map to view the tracker[\/caption]\r\n\r\nOver 25 countries are now moving toward implementation of chlorhexidine for umbilical cord care. The global scale-up tracker is a real-time, interactive dashboard that illustrates the global progress of chlorhexidine implementation and scale-up. Dashboard users can see a wealth of information regarding the current status of chlorhexidine engagement in these countries, including policy status, type of product used, location of use, regulatory status, and locations of local manufacture.[\/vc_cta][vc_row_inner content_placement=\"middle\"][vc_column_inner el_class=\"text-red\" width=\"1\/4\"][vc_column_text]\r\n<h1 style=\"text-align: center;\"><strong><span class=\"ticker\">2.4<\/span>M<\/strong><\/h1>\r\n[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\"3\/4\"][vc_column_text css=\".vc_custom_1651600731322{padding-top: 10px !important;padding-bottom: 10px !important;}\"]\r\n<h3 style=\"text-align: center;\"><span style=\"font-weight: 400;\">Newborn lives are claimed every year across the world*<\/span><\/h3>\r\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_separator][vc_row_inner content_placement=\"middle\"][vc_column_inner el_class=\"text-yellow\" width=\"1\/4\"][vc_column_text]\r\n<h1 style=\"text-align: center;\"><strong><span class=\"ticker\">7<\/span>%<\/strong><\/h1>\r\n[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\"3\/4\"][vc_column_text css=\".vc_custom_1651600713114{padding-top: 10px !important;padding-bottom: 10px !important;}\"]\r\n<h3 style=\"text-align: center;\"><span style=\"font-weight: 400;\">Of the deaths are caused by sepsis and other infectious conditions of the newborn*<\/span><\/h3>\r\n<h6>*Represents the most recent data available. Please visit our <a href=\"https:\/\/www.healthynewbornnetwork.org\/numbers\/\">Newborn Numbers<\/a> page and download the Excel spreadsheet to explore the data further<\/h6>\r\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_separator][vc_row_inner content_placement=\"middle\"][vc_column_inner el_class=\"text-blue\" width=\"1\/4\"][vc_column_text]\r\n<h1 style=\"text-align: center;\"><strong><span class=\"ticker\">23<\/span>%<\/strong><\/h1>\r\n[\/vc_column_text][vc_empty_space][\/vc_column_inner][vc_column_inner width=\"3\/4\"][vc_column_text css=\".vc_custom_1461187100208{padding-top: 10px !important;padding-bottom: 10px !important;}\"]\r\n<h3 style=\"text-align: center;\"><span style=\"font-weight: 400;\">Reduction in neonatal mortality when 7.1% chlorhexidine digluconate was used on the first day of life, as demonstrated by the clinical trials conducted in South Asia.<\/span><\/h3>\r\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row full_width=\"stretch_row\" css=\".vc_custom_1460150566355{margin-top: 0px !important;margin-bottom: 0px !important;border-top-width: 0px !important;background-color: #ffffff !important;}\"][vc_column][vc_cta h2=\"Cautionary note\" color=\"sandy-brown\"]\r\n<h3 style=\"text-align: justify;\"><strong>As with all medications, care must be taken to ensure that the product is used appropriately. 7.1% chlorhexidine digluconate for umbilical cord care should be kept out of eyes and ears and should be applied only to the umbilical stump.<\/strong><\/h3>\r\n<h3 style=\"text-align: justify;\">In 2015, it came\u00a0to the attention of the global Chlorhexidine Working Group (CWG) that 7.1% chlorhexidine digluconate aqueous solution (liquid) for umbilical cord care was mistakenly applied to the eyes of at least five children in Nigeria, causing eye injury.\u00a0\u00a0 Chlorhexidine has been in use for over 50 years and has a well\u2013characterized safety profile when used as directed. The formulation of chlorhexidine digluconate used for cord care (7.1% w\/v), when used as directed, is effective in preventing neonatal sepsis due to bacterial exposure through the fresh umbilical stump. \u00a0However, it can cause serious harm if applied to the eyes and should also not be put into the ear canal. It is important that persons and organizations responsible for chlorhexidine for umbilical cord care programs and for the distribution of the chlorhexidine for umbilical cord care product to caregivers ensure that instruction is provided on the appropriate use of the product, including appropriate warnings.<\/h3>\r\n<h3><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/memorandum-safety-concerns-over-misuse-of-chlorhexidine-chx\/\">Memorandum: Safety Concerns Over Misuse of Chlorhexidine (CHX)<\/a><\/h3>\r\n<h3><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/alert-no-133-chlorhexidine-71-digluconate-chx-reports-of-serious-eye-injury-due-to-errors-in-administration\/\">Alert No. 133: Chlorhexidine 7,1% digluconate (CHX): Reports of serious eye injury due to errors in administration<\/a><\/h3>\r\n[\/vc_cta][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\".vc_custom_1636735661384{background-color: #ef814a !important;}\"]<a name=\"getready\"><\/a>\r\n<h1 style=\"text-align: center;\"><span style=\"color: #ffffff;\"><strong>Get Ready<\/strong><\/span><\/h1>\r\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=\"1\/2\"][vc_column_text]\r\n<p style=\"text-align: justify;\">Successful program implementation requires the coordinated effort of the key stakeholders and alignment of policies and guidelines. The first step is to <strong>gain consensus<\/strong> through consultations with various key stakeholders in the public and private sectors. Further <strong>evidence for implementation<\/strong> may need to be generated if stakeholders believe that gaps in operational evidence exist. The final component of coordinating the effort is to <strong>align policies and guidelines<\/strong> for chlorhexidine implementation.<\/p>\r\n<a href=\"#top\"><strong>Back to CHX HOMEPAGE<\/strong><\/a>[\/vc_column_text][\/vc_column][vc_column width=\"1\/2\"][vc_single_image image=\"15591\"][\/vc_column][\/vc_row][vc_row][vc_column][vc_text_separator title=\"Resources\"][\/vc_column][\/vc_row][vc_row][vc_column width=\"1\/2\"][vc_column_text]<a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/activity-1-gaining-consensus-chlorhexidine\/\"><strong>Activity 1: Gaining Consensus<\/strong><\/a>\r\n<ul>\r\n \t<li>CWG Tech Brief (<a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-technical-brief-umbilical-cord-cleansing-saves-newborn-lives\/\" target=\"_blank\" rel=\"noopener noreferrer\">English<\/a>,<a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/CHX-Technical-Brief_final-for-translation__2017-11-20_FR-1.pdf\">\u00a0fran\u00e7ais<\/a>,\u00a0<a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/CHX-Technical-Brief_final-for-translation__2017-11-20_PT-1.pdf\">Portugu\u00eas<\/a>)<\/li>\r\n \t<li>CWG Chlorhexidine Products and Uses\u00a0in Healthcare (<a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-products-and-uses-in-health-care\/\" target=\"_blank\" rel=\"noopener noreferrer\">English<\/a>,\u00a0<a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/les-produits-a-base-de-chlorhexidine-et-leurs-utilisations-dans-le-domaine-des-soins-de-sante\/\" target=\"_blank\" rel=\"noopener noreferrer\">fran\u00e7ais<\/a>,\u00a0<a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/CWG-Chlorhexidine-Applications-PT_Aug_2015-2015-08-20.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Portugu\u00eas<\/a>)<\/li>\r\n \t<li>UN Commission on Life-Saving Commodities for Women and Children\u00a0<a href=\"http:\/\/www.path.org\/publications\/detail.php?i=2381\" target=\"_blank\" rel=\"noopener noreferrer\">Policy\/Advocacy Toolkit<\/a><\/li>\r\n \t<li>Results of the randomized controlled trials in\u00a0<a href=\"http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(06)68381-5\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">Nepal<\/a>,\u00a0<a href=\"http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(11)61848-5\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">Bangladesh<\/a>, and\u00a0<a href=\"http:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(11)61877-1\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">Pakistan<\/a>, and the\u00a0<a href=\"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-13-S3-S15\" target=\"_blank\" rel=\"noopener noreferrer\">meta-analysis<\/a>\u00a0of the three trials<\/li>\r\n \t<li>Chlorhexidine gel versus aqueous solution\u00a0<a href=\"http:\/\/journals.lww.com\/pidj\/Abstract\/2010\/11000\/Chlorhexidine_Gel_Versus_Aqueous_for_Preventive.4.aspx\" target=\"_blank\" rel=\"noopener noreferrer\">randomized noninferiority trial<\/a><\/li>\r\n \t<li>Chlorhexidine\u00a0<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2386993\/\" target=\"_blank\" rel=\"noopener noreferrer\">safety data<\/a><\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-for-umbilical-cord-care-game-changer-for-newborn-survival\/\" target=\"_blank\" rel=\"noopener noreferrer\">Chlorhexidine for umbilical cord care: game-changer for newborn survival?<\/a><\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/DRC-Group-work_outline.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">DRC Technical Working Group structure and outline<\/a>\u00a0(fran\u00e7ais)<\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/R%C3%A9sum%C3%A9-sur-les-%C3%A9vidences-scientifiques-de-lutilisation-de-la-Chlorhexidine-digluconate-7-1_0.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">DRC\u00a0R\u00e9sum\u00e9 sur les \u00e9vidences scientifiques de l\u2019utilisation de la Chlorhexidine(CHX) digluconate 7.1%<\/a>\u00a0(fran\u00e7ais) \u00a0[DRC scientific evidence presentation]<\/li>\r\n \t<li><a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/CHX-Nepal-meeting-report-12-02-2011-FINAL-1.pdf\">Chlorhexidine for Umbilical Cord Care: Evidence Base and the Way Forward<\/a><\/li>\r\n \t<li><a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Coffey-P.-et-al.-umbilical-cord-care-practice-in-low-and-middle-income-countries-1.pdf\">Umbilical cord-care practices in low- and middle-income countries: a systematic review<\/a><\/li>\r\n \t<li><a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Final_CHX_Meeting-Report_EN_140429.pdf\">Technical Report: Report on the Regional Meeting for Francophone West Africa on the use of Chlorhexidine for Umbilical Cord Care<\/a><\/li>\r\n \t<li><a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Herrick-et-al_Modeling-the-potential-impact-of-emerging-innovations_2017.pdf\">Modeling the potential impact of emerging innovations on achievement of Sustainable Development Goals related to maternal, newborn, and child health<\/a><\/li>\r\n \t<li><a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Mullany_Safety-and-impact-of-chlorhexidine-antisepsis-interventions_Ped-Inf-Dis-J_2006.pdf\">Safety and Impact of Chlorhexidine Antisepsis Interventions for Improving Neonatal Health in Developing Countries<\/a><\/li>\r\n \t<li><a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Sazawal-S-et-al-Pemba-Island-chlorhexidine-trial-Lancet-GH-2016.pdf\">Efficacy of chlorhexidine application to umbilical cord on neonatal mortality in Pemba, Tanzania: a community-based randomized controlled trial<\/a><\/li>\r\n \t<li><a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Semrau-KEA-et-al-ZamCAT-main-analysis-Lancet-GH-2016.pdf\">Effectiveness of 4% chlorhexidine umbilical cord care on neonatal mortality in Southern Province, Zambia (ZamCAT): a cluster-randomised controlled trial<\/a><\/li>\r\n \t<li>Antiseptic brief (<a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Antiseptic-brief_Final-for-translation_11-30-17_EN.pdf\">English<\/a>,\u00a0<a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Antiseptic-brief_Final-for-translation_3-11-30-17_FR.pdf\">fran\u00e7ais<\/a>,\u00a0<a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Antiseptic-brief_Final-for-translation_3-11-30-17_PT.pdf\">Portugu\u00eas<\/a>)<\/li>\r\n \t<li>Generic CHX PPT\u00a0(<a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Final-for-translation_Generic-CHX-Presentation-updated-January-19-2018.pptx\">English<\/a>,\u00a0<a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Final-for-translation_Generic-CHX-Presentation-updated-January-19-2018_F....pptx\">fran\u00e7ais<\/a>,\u00a0<a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Final-for-translation_Generic-CHX-Presentation-updated-January-19-2018_P....pptx\">Portugu\u00eas<\/a>)<\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/the-innovation-countdown-report-2030-reimagining-global-health\/\">The Innovation Countdown Report 2030: Reimagining global health<\/a><\/li>\r\n<\/ul>\r\n[\/vc_column_text][vc_column_text][\/vc_column_text][\/vc_column][vc_column width=\"1\/2\"][vc_column_text]<a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/activity-2-building-evidence-implementation-chlorhexidine\/\"><strong>Activity 2: Building Evidence for Implementation<\/strong><\/a>\r\n<ul>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Madagascar-Formative-Research-Presentation_English.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Madagascar formative research<\/a><\/li>\r\n \t<li><a href=\"https:\/\/bmcinthealthhumrights.biomedcentral.com\/articles\/10.1186\/1472-698X-14-12\">Ethiopia formative research<\/a><\/li>\r\n \t<li>Bangladesh operations research<a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Bangladesh_CHX-operations-research_report_2010Jan20.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">\u00a0report\u00a0<\/a>and\u00a0<a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Bangladesh_Programatic-Presentation_Winch-2011.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">presentation<\/a><\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/PATH-Chlorhexidine-Product-Attribute-Study-Bangladesh-2008.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Bangladesh product attribute study<\/a><\/li>\r\n \t<li>India (Uttar Pradesh)\u00a0<a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/results-from-chx-survey-india\/\" target=\"_blank\" rel=\"noopener noreferrer\">formative research\u00a0results<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-end-to-end-analysis-focusing-on-uttar-pradesh\/\" target=\"_blank\" rel=\"noopener noreferrer\">end-to-end analysis<\/a><\/li>\r\n \t<li><a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/CHX-Market-Research-in-Kenya_PATH-FINAL_19Feb2015.pdf\">Market research for 7.1% chlorhexidine digluconate: Kenya<\/a><\/li>\r\n \t<li><a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/FINAL_Nigeria-market-research_v9_12.9.2014.pdf\">Market research for 7.1% chlorhexidine digluconate: Nigeria<\/a><\/li>\r\n \t<li><a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Muriuki-et-al_KenyaCHX_2017.pdf\">Health care providers\u2019 perspectives regarding the use of chlorhexidine gel for cord care in neonates in rural Kenya: implications for scale-up<\/a><\/li>\r\n \t<li><a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Walsh-et-al_Newborn-Cord-Care-Practices-in-Haiti.pdf\">Newborn cord care practices in Haiti<\/a><\/li>\r\n<\/ul>\r\n<a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/activity-3-aligning-policies-guidelines-chlorhexidine\/\"><strong>Activity 3: Aligning Policies and Guidelines<\/strong><\/a>\r\n<ul>\r\n \t<li>CWG\u00a0Country Guidance\u00a0(<a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Final-for-translation_CWG-Country-Guidance_Jan-19-2018_EN.pdf\">English<\/a>,\u00a0<a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Final-for-translation_CWG-Country-Guidance_Jan-19-2018_FR.pdf\">fran\u00e7ais<\/a>,\u00a0<a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Final-for-translation_CWG-Country-Guidance_Jan-19-2018_PT.pdf\">Portugu\u00eas<\/a>)<\/li>\r\n \t<li>CWG\u00a0<a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/CWG-Supplementary-Country-Guidance-EN_Sept_2015-2015-08-21.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Supplementary Country Guidance<\/a><\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Policy-Developement-DRC-CHX-FR-format.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">DRC \u00c9laboration d\u2019une politique nationale concernant l\u2019introduction de la chlorhexidine \u00e0 7,1 % pour les soins du cordon ombilical<\/a>\u00a0(fran\u00e7ais) [DRC national policy development plan]<\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Ghana_Chlorhexidine-Policy-Brief-FINAL.pdf\">Chlorhexidine Digluconate 7.1% Gel Press Release<\/a><\/li>\r\n<\/ul>\r\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\".vc_custom_1460145487524{background-color: #ef814a !important;}\"]<a name=\"plan\"><\/a>\r\n<h1 style=\"text-align: center;\"><span style=\"color: #ffffff;\"><strong>Plan<\/strong><\/span><\/h1>\r\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=\"1\/2\"][vc_column_text]\r\n<p style=\"text-align: justify;\">The next phase should be to plan for initial implementation. Key components of implementation planning include: developing\u00a0<strong>demand generation<\/strong> strategies, <strong>orientation and training<\/strong>\u00a0of service providers, considering <strong>product manufacturing and distribution<\/strong> options, developing a <strong>monitoring and evaluation<\/strong> plan, and developing a <strong>financing<\/strong> strategy.<\/p>\r\n<a href=\"#top\"><strong>Back to CHX HOMEPAGE<\/strong><\/a>[\/vc_column_text][\/vc_column][vc_column width=\"1\/2\"][vc_single_image image=\"16266\" onclick=\"custom_link\" img_link_target=\"_blank\" link=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/HNN-Chlorhexidine-PLAN-Graphic.jpg\"][\/vc_column][\/vc_row][vc_row][vc_column][vc_text_separator title=\"Resources\"][\/vc_column][\/vc_row][vc_row][vc_column width=\"1\/2\"][vc_column_text]<a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/component-1-integrating-demand-generation-chlorhexidine\/\"><strong>Component 1: Integrating Demand Generation<\/strong><\/a>\r\n<ul>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/driving-demand-chlorhexidine-human-centered-design-toolkit-development-demand-generation-materials\/\">Driving Demand for Chlorhexidine<\/a>: a human-centered design toolkit for the development of\u00a0demand generation materials<\/li>\r\n \t<li>Demand Generation\u00a0<a href=\"http:\/\/sbccimplementationkits.org\/demandrmnch\/\" target=\"_blank\" rel=\"noopener noreferrer\">Implementation Kit (I-Kit)<\/a>\u00a0for Underutilized, Life-Saving Commodities<\/li>\r\n \t<li>Madagascar\u00a0<a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/madagascar-chlorhexidine-flyer\/\" target=\"_blank\" rel=\"noopener noreferrer\">flyer<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/madagascar-chlorhexidine-poster\/\" target=\"_blank\" rel=\"noopener noreferrer\">poster<\/a>\u00a0for AroFoitra (Malagasy)<\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Resultats-du-pretest-des-materiels-IEC-pour-AroFoitra-.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Madagascar Resultats du pretest des materiels IEC pour AroFoitra<\/a>\u00a0(fran\u00e7ais) \u00a0[results of the pretest of IEC materials for AroFoitra]<\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Plan-com-CHX_final1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Madagascar Strat\u00e9gie de communication<\/a>\u00a0(fran\u00e7ais)\u00a0[Madagascar communication strategy for AroFoitra]<\/li>\r\n<\/ul>\r\n[\/vc_column_text][vc_column_text]<a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/component-2-orientationtraining-chlorhexidine\/\"><strong>Component 2: Orientation\/Training<\/strong><\/a>\r\n<ul>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Nepal_Chlorhexidine-Training-Manual2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Training materials for single-day application<\/a>\u00a0(from Nepal)<\/li>\r\n \t<li><a href=\"http:\/\/www.medicalaidfilms.org\/film\/how-to-use-chlorhexidine-for-umbilical-cord-care\/\" target=\"_blank\" rel=\"noopener noreferrer\">How to use chlorhexidine for umbilical cord care<\/a>\u00a0(link to training video)<\/li>\r\n \t<li>Madagascar formation des agents de sante (fran\u00e7ais)\u00a0[Madagascar health worker training materials]\r\n<ul>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/programme-introductive-de-prevention-de-linfection-du-nouveau-ne-par-la-chlorhexidine-71-pommade-formation-des-agents-de-sante-cahier-du-formateur\/\" target=\"_blank\" rel=\"noopener noreferrer\">Cahier du formateur<\/a>\u00a0[trainer notebook]<\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/programme-introductive-de-prevention-de-linfection-du-nouveau-ne-par-la-chlorhexidine-71-pommade-formation-des-agents-de-sante-carnet-du-participant\/\" target=\"_blank\" rel=\"noopener noreferrer\">Carnet du participant<\/a>\u00a0[participant book]<\/li>\r\n<\/ul>\r\n<\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/madagascar-chlorhexidine-job-aid\/\" target=\"_blank\" rel=\"noopener noreferrer\">Madagascar job aid<\/a>\u00a0(Malagasy)<\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Nepal_Poster-Kawach-eng.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Nepal job aid<\/a><\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-training-manual-sbas-lhws-sindh-pakistan\/\" target=\"_blank\" rel=\"noopener noreferrer\">Sindh Province (Pakistan) training materials<\/a><\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/TS_CHX_IFU_Poster_Update_v3_rev04.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Aqueous solution (liquid) instructions for use<\/a><\/li>\r\n \t<li><a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/CHX-Posters05-PRESS02-how-to-use_Kenya.pdf\">How to apply chlorhexidine gel and solution: Instructions for use from Kenya<\/a><\/li>\r\n \t<li>Brief on correct use (<a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Brief-on-Correct-Use_Final-for-translation_12-05-17_EN.pdf\">English<\/a>,\u00a0<a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Brief-on-Correct-Use_Final-for-translation_2-12-05-17_FR.pdf\">fran\u00e7ais<\/a>,\u00a0<a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Brief-on-Correct-Use_Final-for-translation_2-12-05-17_PT.pdf\">Portugu\u00eas<\/a>)<\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/path-chlorhexidine-product-attribute-study-2008\/\">PATH Chlorhexidine Product Attribute Study (2008)<\/a><\/li>\r\n<\/ul>\r\n[\/vc_column_text][vc_column_text][\/vc_column_text][\/vc_column][vc_column width=\"1\/2\"][vc_column_text]<a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/component-3-product-manufacturing-distribution-chlorhexidine\/\"><strong>Component 3: Product Manufacturing and Distribution<\/strong><\/a>\r\n<ul>\r\n \t<li>Chlorhexidine Market Sizing Tool (Utilizing\u00a0<a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-market-sizing-tool-utilizing-user-estimates\/\" target=\"_blank\" rel=\"noopener noreferrer\">User Estimates<\/a>, Utilizing\u00a0<a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-market-sizing-tool-utilizing-market-size-estimates\/\" target=\"_blank\" rel=\"noopener noreferrer\">Market Size Estimates<\/a>)<\/li>\r\n \t<li>CWG Production Strategy (<a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/CWG-Production-Strategy-EN_November_2015-2015-11-06.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">English<\/a>,\u00a0<a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/CWG-Production-Strategy-FR_November-2015-2015-11-06.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">fran\u00e7ais<\/a>)<\/li>\r\n \t<li>CWG\u00a0<a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/CWG-Guidance-to-Procurers-EN_APR_2016.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Procurement Guidance<\/a><\/li>\r\n \t<li>CWG\u00a0<a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/list-of-manufacturers-of-7-1-chlorhexidine-digluconate-for-umbilical-cord-care-2021\/\">List of manufacturers of 7.1% chlorhexidine digluconate for umbilical cord care<\/a><\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/CWG-Standard-Patient-Information-Leaflet-English_October_2015.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Patient information\u00a0leaflet<\/a><\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Chlorhexidine-in-Nepal-A-Public-Private-Partnership-Case-Study.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Nepal Public Private Partnership Case Study<\/a><\/li>\r\n<\/ul>\r\n[\/vc_column_text][vc_column_text]<a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/component-4-monitoring-evaluation-chlorhexidine\/\"><strong>Component 4: Monitoring and Evaluation (M&amp;E)<\/strong><\/a>\r\n<ul>\r\n \t<li>CWG\u00a0<a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Performance-Indicators-CHX.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Performance Indicators<\/a><\/li>\r\n \t<li>Every Newborn Action Plan\u00a0<a href=\"http:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/1471-2393-15-S2-S8\" target=\"_blank\" rel=\"noopener noreferrer\">indicators<\/a>\u00a0(includes chlorhexidine)<\/li>\r\n \t<li><a href=\"http:\/\/dhsprogram.com\/publications\/publication-DHSQM-DHS-Questionnaires-and-Manuals.cfm\" target=\"_blank\" rel=\"noopener noreferrer\">Demographics and Health Surveys (DHS) newborn module<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.livessavedtool.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">Lives Saved Tool (LiST)<\/a><\/li>\r\n \t<li>Demographic and Health Surveys (DHS)\u00a0<a href=\"http:\/\/dhsprogram.com\/pubs\/pdf\/DHSQM\/DHS7_Module_Newborn_Care_EN_01Mar2016_DHSQM.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">newborn module<\/a><\/li>\r\n<\/ul>\r\n[\/vc_column_text][vc_column_text]<strong>Component 5: Financing\u00a0 <\/strong>\r\n<ul>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/national-strategy-for-scale-up-of-chlorhexidine-in-nigeria\/\">National Strategy For Scale-Up Of Chlorhexidine in Nigeria<\/a><\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-costed-scale-up-plan-in-madagascar\/\">Chlorhexidine costed scale-up plan in Madagascar<\/a><\/li>\r\n<\/ul>\r\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\".vc_custom_1460145515019{background-color: #ef814a !important;}\"]<a name=\"execute\"><\/a>\r\n<h1 style=\"text-align: center;\"><span style=\"color: #ffffff;\"><strong>Execute<\/strong><\/span><\/h1>\r\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=\"1\/2\"][vc_column_text]\r\n<p style=\"text-align: justify;\">The final phase is to execute the CHX implementation plan and continuously monitor how it is being implemented to determine if the desired outcomes are being achieved. Data from the initial phase of implementation should be disseminated to key stakeholders within the country. If the program is not being implemented as planned, corrective action should be taken. Ministries of Health or key stakeholders may wish to disseminate data about the progress of CHX implementation in their country through international conferences or publications to help other countries accelerate implementation of CHX.<\/p>\r\n<a href=\"#top\"><strong>Back to CHX HOMEPAGE<\/strong><\/a>[\/vc_column_text][\/vc_column][vc_column width=\"1\/2\"][vc_single_image image=\"15603\"][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]\r\n<ul>\r\n \t<li>Chlorhexidine for umbilical cord care\u00a0presentations at the Global Maternal Newborn Health Conference (October 2015):\r\n<ul>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Introduction-of-Chlorhexidine-in-Sindh-Pakistan.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Introduction of Chlorhexidine in Sindh, Pakistan<\/a> (MCHIP)<\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/INTRODUCTION-DE-LA-CHLORHEXIDINE-DIGLUCONATE-71-EN-RDC.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Introduction de la Chlorhexidine Digluconate 7,1% dans les soins ombilicaux en RDC<\/a> (MSH\/SIAPS)<\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Saving-the-Pair-%E2%80%93-Integrated-Scale-up-of-CHX-and-Miso-in-Rural-Madagascar.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Saving the Pair \u2013Integrated Scale-up of Chlorhexidine and Misoprostol for Newborns and Mothers in Rural Madagascar<\/a> (JSI Research and Training Institute)<\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Institutionalizing-Chlorhexidine-Program-and-Maintaining-Coverage-in-Nepal.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Institutionalizing Chlorhexidine Program and Maintaining Coverage Chlorhexidine Cord Care Program in Nepal<\/a> (JSI Research and Training Institute)<\/li>\r\n<\/ul>\r\n<\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Timeline-Nepal-progress-towards-CHX-sustainability.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Nepal progress towards program sustainability (timeline)<\/a><\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/national-strategy-for-scale-up-of-chlorhexidine-in-nigeria\/\">National Strategy For Scale-Up Of Chlorhexidine in Nigeria<\/a><\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-costed-scale-up-plan-in-madagascar\/\">Chlorhexidine costed scale-up plan in Madagascar<\/a><\/li>\r\n \t<li><a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/CWG-Implementation-Guide-3-1.pdf\">Guide to implementing 7.1% chlorhexidine digluconate for umbilical cord care: Three phases to ensure sustainable implementation<\/a><\/li>\r\n \t<li><a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Establishing-Quality-Product-Supply-of-Chlorhexidine-for-Umbilical-Cord-Care.pptx\">Establishing Quality Product Supply of Chlorhexidine for Umbilical Cord Care<\/a><\/li>\r\n \t<li><a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Institutionalizing-Chlorhexidine-Program-and-Maintaining-Coverage-in-Nepal.ppt\">Institutionalizing Chlorhexidine Program and Maintaining Coverage in Nepal<\/a><\/li>\r\n \t<li><a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/INTRODUCTION-DE-LA-CHLORHEXIDINE-DIGLUCONATE-71-EN-RDC.pptx\">Introduction de la chlorhexidine digluconate 7,1% dans les soins ombilicaux en RDC (fran\u00e7ais) [Introduction of 7.1% chlorhexidine digluconate for umbilical cord care in DRC]<\/a><\/li>\r\n \t<li><a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Saving-the-Pair_Integrated-Scale-up-of-CHX-and-Miso-in-Rural-Madagascar.ppt\">Saving the Pair: Integrated Scale-up of Chlorhexidine and Misoprostol in Rural Madagascar<\/a><\/li>\r\n \t<li><a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Timeline-Nepal-progress-towards-CHX-sustainability-1.pdf\">Timeline of Nepal progress towards CHX program sustainability<\/a><\/li>\r\n \t<li><a href=\"\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/CHXstory_From-Research-to-Use_01.22.18-1.pdf\">From Research to Use: Saving Newborn Lives With Chlorhexidine for Umbilical Cord Care<\/a><\/li>\r\n<\/ul>\r\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\".vc_custom_1460149292456{background-color: #ef814a !important;}\"]<a name=\"about\"><\/a>\r\n<h1 style=\"text-align: center;\"><span style=\"color: #ffffff;\"><strong>About<\/strong><\/span><\/h1>\r\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=\"1\/2\"][vc_column_text]\r\n<p style=\"text-align: justify;\">The Chlorhexidine Working Group (CWG) is an international collaboration of organizations committed to advancing the use of 7.1% chlorhexidine digluconate (delivering 4% chlorhexidine) for umbilical cord care through advocacy and technical assistance. PATH serves as the Secretariat of the CWG.<\/p>\r\n<a href=\"#top\"><strong>Back to CHX HOMEPAGE<\/strong><\/a>[\/vc_column_text][\/vc_column][vc_column width=\"1\/2\"][vc_single_image image=\"15798\"][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]\r\n<ul>\r\n \t<li>CWG <a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/CWG-terms-of-reference_April-2016.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Terms of Reference<\/a><\/li>\r\n \t<li>CWG <a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/NEW-FORMAT_CWG-strategy-statement_03.20.15-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Strategy Statement<\/a><\/li>\r\n \t<li>CWG Capacity Statement (<a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/CWG-Capacity-Statement-English_August_2015.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">English<\/a>, <a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/CWG-Capacity-Statement-PT_Aug_2015-2015-08-20.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Portugu\u00eas<\/a>)<\/li>\r\n<\/ul>\r\n<strong>Members include individuals representing:<\/strong>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=\"1\/2\"][vc_column_text]\r\n<ul>\r\n \t<li>PATH [Secretariat]<\/li>\r\n \t<li>ayzh<\/li>\r\n \t<li>Bill &amp; Melinda Gates Foundation<\/li>\r\n \t<li>Boston University<\/li>\r\n \t<li>Burnet Institute<\/li>\r\n \t<li>Centre for Infectious Disease Research in Zambia<\/li>\r\n \t<li>Clinton Health Access Initiative<\/li>\r\n \t<li>Drugfield Pharmaceuticals Ltd. (Nigeria)<\/li>\r\n \t<li>Duke University<\/li>\r\n \t<li>Global Health Action<\/li>\r\n \t<li>Jhpiego<\/li>\r\n \t<li>John Snow, Inc.<\/li>\r\n \t<li>Johns Hopkins Bloomberg School of Public Health<\/li>\r\n \t<li>Johnson &amp; Johnson (USA)<\/li>\r\n \t<li>Lomus Pharmaceuticals Pvt. Ltd. (Nepal)<\/li>\r\n \t<li>Maternal and Child Survival Program<\/li>\r\n \t<li>Ministry of Health, DRC (Reproductive Health)<\/li>\r\n<\/ul>\r\n[\/vc_column_text][\/vc_column][vc_column width=\"1\/2\"][vc_column_text]\r\n<ul>\r\n \t<li>Ministry of Health, Ethiopia (Maternal &amp; Child Health)<\/li>\r\n \t<li>Ministry of Health, Kenya (Child &amp; Adolescent Health)<\/li>\r\n \t<li>Ministry of Health, Liberia (Family Health)<\/li>\r\n \t<li>Ministry of Health, Malawi (Reproductive Health)<\/li>\r\n \t<li>Ministry of Health, Mozambique (Child Health)<\/li>\r\n \t<li>Promoting the Quality of Medicines\/United States Pharmacopeia<\/li>\r\n \t<li>PSI<\/li>\r\n \t<li>Save the Children\/Saving Newborn Lives<\/li>\r\n \t<li>SHOPS Plus\/Abt Associates<\/li>\r\n \t<li>Systems for Improved Access to Pharmaceuticals and Services\/Management Sciences for Health<\/li>\r\n \t<li>United Nations Children\u2019s Fund<\/li>\r\n \t<li>United States Agency for International Development<\/li>\r\n \t<li>Universal Corporation Ltd. (Kenya)<\/li>\r\n \t<li>University of Illinois at Chicago<\/li>\r\n \t<li>University Research Corporation<\/li>\r\n \t<li>World Health Organization<\/li>\r\n<\/ul>\r\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\".vc_custom_1511361090172{background-color: #ef814a !important;}\"]<a name=\"country\"><\/a>\r\n<h1 style=\"text-align: center;\"><span style=\"color: #ffffff;\"><strong>Country Specific Resources<\/strong><\/span><\/h1>\r\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<strong>Bangladesh: <\/strong>\r\n<ul>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/bangladesh-national-newborn-health-situation-analysis-report-2014\/\">National Newborn Health Situation Analysis Report 2014<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/end-preventable-child-deaths-2035-bangladesh-call-action\/\">End preventable child deaths by 2035: Bangladesh Call for Action <\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/bangladesh-chlorhexidine-operations-research-study-2008-2009\/\">Bangladesh chlorhexidine operations research study 2008-2009<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/impact-of-cord-cleansing-with-chlorhexidine-on-neonatal-mortality-in-rural-bangladesh-a-communitybased-clusterrandomised-trial\/\">Impact of cord cleansing with chlorhexidine on neonatal mortality in rural Bangladesh a community based trial<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Bangladesh_CHX-operations-research_phase-2-user-instructions_English_2009Feb01.pdf\">Chlorhexidine poster<\/a><\/li>\r\n<\/ul>\r\n<strong>Democratic Republic of the Congo:<\/strong>\r\n<ul>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/INTRODUCTION-DE-LA-CHLORHEXIDINE-DIGLUCONATE-71-EN-RDC.pdf\">Chlorhexidine Introduction in the DRC <\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/overview-of-the-chlorhexidine-work-structure-for-democratic-republic-of-the-congo\/\">Chlorhexidine working group structure in the DRC<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Infection-ombilicale.pdf\">Chlorhexidine PowerPoint Presentation <\/a><\/li>\r\n<\/ul>\r\n<strong>India: <\/strong>\r\n<ul>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/effect-4-chlorhexidine-cord-colonization-among-hospital-community-births-india-randomized-controlled-study\/\">Effect of 4% chlorhexidine on cord colonization among hospital and community births in India: a randomized controlled study<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/CHX-End-to-End-CHX-WG-121230.pdf\">Chlorhexidine end-to-end analysis focusing on Uttar Pradesh <\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/results-from-chx-survey-india\/\">Results from chlorhexidine survey<\/a><\/li>\r\n<\/ul>\r\n<strong>Madagascar<\/strong>:\r\n<ul>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/presentation-des-resultats-du-pretest-des-materiels-iec-pour-arofoitra\/\">Results of the pretest of IEC materials for the chlorhexidine program in Madagascar<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/madagascar-chlorhexidine-formative-research-presentation\/\">Chlorhexidine Formative Research Presentation <\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/madagascar-chlorhexidine-job-aid\/\">Chlorhexidine Job Aid<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/madagascar-chlorhexidine-flyer\/\">Chlorhexidine Flyer<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/madagascar-chlorhexidine-poster\/\">Chlorhexidine Poster <\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/programme-introductive-de-prevention-de-linfection-du-nouveau-ne-par-la-chlorhexidine-71-pommade-formation-des-agents-de-sante-cahier-du-formateur\/\">Training toolkit for community health workers <\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/saving-pair-integrated-scale-chlorhexidineand-misoprostol-newborns-mothers-rural-madagascar\/\">Saving the Pair \u2013Integrated Scale-up of Chlorhexidine and Misoprostol for Newborns and Mothers in Rural Madagascar<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-costed-scale-up-plan-in-madagascar\/\">Chlorhexidine Scale-up Plan<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Notice-CHX-FB01.pdf\">Chlorhexidine medical notice<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/arofoitra-flyer-malagasy\/\">Chlorhexidine Flyer<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/investiguer-les-pratiques-courantes-et-les-perceptions-autour-du-soin-du-cordon-ombilical-et-lacceptabilite-de-arofoitra-par-les-cibles\/\">Study on umbilical cord care practices<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Plan-com-CHX_final1.pdf\">Communications Strategy<\/a><\/li>\r\n<\/ul>\r\n<strong>Nepal: <\/strong>\r\n<ul>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/timeline-nepals-progress-towards-chlorhexidine-program-sustainability\/\">Timeline of Nepal\u2019s progress towards chlorhexidine program sustainability<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/institutionalizing-chlorhexidine-program-maintaining-coverage-chlorhexidine-cord-care-program-nepal\/\">Institutionalizing Chlorhexidine Program and Maintaining Coverage \u2013 Chlorhexidine Cord Care Program in Nepal<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/introducing-chlorhexidine-in-nepal\/\">Chlorhexidine Introduction in Nepal<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-in-nepal-a-public-private-partnership-case-study\/\">Case Study<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-in-nepal-a-public-private-partnership-case-study-july-2013\/\">USAID, JSI Nepal Case Study <\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/innovation-in-reducing-neonatal-death-using-chlorhexidine-in-nepal-a-case-study\/\">Innovation in reducing neonatal death using Chlorhexidine in Nepal- a case study<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-cleansing-of-the-umbilical-cord-in-nepal-leading-by-example-and-saving-lives\/\">Chlorhexidine cleansing of the umbilical cord in Nepal: leading by example and saving lives<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/study-on-cord-care-practices-focus-group-discussion-with-occupational-castes\/\">Study on cord care practices focus group discussion<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/a-study-on-cord-care-practices-semi-structured-interview-with-recently-delivered-women\/\">Semi-structured interview with mothers who recently gave birth<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/a-study-on-cord-care-practices-semi-structured-interview-with-mothers-in-law\/\">Semi-structured interview with mother-in laws<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/a-study-on-cord-care-practices-focus-group-discussion-with-mothers-in-law\/\">Study on cord care practices focus group discussion with mother in laws<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/study-on-cord-care-practices-semi-structured-interview-with-cord-cutting-occupational-groups\/\">Semi-structured interview with cord cutting occupational groups<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-navi-care-program\/\">Chlorhexidine poster<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Nepal_CHX-presentation-for-Nigeria-meeting_October2012.pdf\">Nepal chlorhexidine presentation<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-navi-care-program-2\/\">Chlorhexidine navi care program<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/preliminary-experience-with-chlorhexidine-for-cord-care-in-nepal\/\">Preliminary experience with chlorhexidine for cord care in Nepal<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/fighting-newborn-infection-chlorhexidine-in-rural-nepal\/\">Fighting newborn infection in rural Nepal<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/community-trial-of-newborn-skin-and-umbilical-cord-cleansing-on-neonatal-mortality-in-nepal\/\">Community trial of newborn skin and umbilical cord cleansing on neonatal mortality in Nepal<\/a><\/li>\r\n<\/ul>\r\n<strong>Nigeria: <\/strong>\r\n<ul>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/nigeria-every-newborn-action-plan-a-plan-to-end-preventable-newborn-deaths-in-nigeria-launch-version\/\">Nigeria Every Newborn Action Plan: A Plan to End Preventable Newborn Deaths in Nigeria<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/national-strategy-for-scale-up-of-chlorhexidine-in-nigeria\/\">National Strategy for Scale-up of Chlorhexidine in Nigeria<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/RESOURCE_MamaYe-Nigeria-leaflet-drugs.pdf\">Mame Ye Nigeria brochure <\/a><\/li>\r\n<\/ul>\r\n<strong>Pakistan:\u00a0 <\/strong>\r\n<ul>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/chlorhexidine-training-manual-sbas-lhws-sindh-pakistan\/\">Chlorhexidine Training Manual for SBAs and LHWs <\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/introduction-chlorhexidine-sindh-pakistan\/\">Introduction of chlorhexidine in Pakistan<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.healthynewbornnetwork.org\/resource\/evaluation-of-topical-application-of-chlorhexidine-to-the-umbilical-cord-for-reduction-in-omphalitis-neonatal-mortality-in-pakistan\/\">Evaluation of topical application of chlorhexidine to the umbilical cord for reduction in omphalitis neonatal mortality in Pakistan<\/a><\/li>\r\n<\/ul>\r\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]","post_title":"Chlorhexidine for umbilical cord care","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"chlorhexidine-for-umbilical-cord-care","to_ping":"","pinged":"","post_modified":"2022-09-20 16:54:48","post_modified_gmt":"2022-09-20 20:54:48","post_content_filtered":"","post_parent":0,"guid":"http:\/\/www.healthynewbornnetwork.org\/?post_type=issue&#038;p=118","menu_order":0,"post_type":"issue","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":408,"post_author":"7211","post_date":"2016-01-20 17:59:41","post_date_gmt":"2016-01-20 17:59:41","post_content":"[vc_row full_width=\"stretch_row\" css=\".vc_custom_1453403441710{margin-top: -60px !important;padding-top: 30px !important;padding-bottom: 30px !important;background-color: #ffffff !important;}\"][vc_column width=\"1\/2\"][vc_column_text]\r\n<h2>While the term \u201cessential newborn care\u201d can be used in a variety of ways, the Healthy Newborn Network uses the term to refer to key routine practices in the care of the newborn, particularly at the time of birth and over the first hours of life, whether in the health facility or at home.<\/h2>\r\n[\/vc_column_text][\/vc_column][vc_column width=\"1\/2\" el_class=\"issue-stats\"][vc_row_inner content_placement=\"middle\"][vc_column_inner el_class=\"text-red\" width=\"1\/3\"][vc_column_text]\r\n<h1 style=\"text-align: center;\"><strong><span class=\"ticker\">800<\/span>k<\/strong><\/h1>\r\n[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\"2\/3\"][vc_column_text css=\".vc_custom_1667425498849{padding-top: 10px !important;padding-bottom: 10px !important;}\"]\r\n<h3 style=\"text-align: center;\"><span style=\"font-weight: 400;\">number of children under age 5 who <a href=\"https:\/\/www.healthynewbornnetwork.org\/blog\/the-lancet-breastfeeding-series\/\">might be saved every year<\/a> if optimally breastfed<\/span><\/h3>\r\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_separator][vc_row_inner content_placement=\"middle\"][vc_column_inner el_class=\"text-yellow\" width=\"1\/3\"][vc_column_text]\r\n<h1 style=\"text-align: center;\"><strong><span class=\"ticker\">44<\/span><\/strong><\/h1>\r\n[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\"2\/3\"][vc_column_text css=\".vc_custom_1666041181328{padding-top: 10px !important;padding-bottom: 10px !important;}\"]\r\n<h3 style=\"text-align: center;\"><span style=\"font-weight: 400;\">percent of babies who are exclusively breastfed during their first six months of life globally (2014-2020)<\/span><\/h3>\r\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_separator][vc_row_inner content_placement=\"middle\"][vc_column_inner][vc_column_text]\r\n<h6 style=\"text-align: center;\"><span style=\"font-style: italic;\">All data on this page represents the most recent data available, unless otherwise noted. Please visit our\u00a0<\/span><a href=\"https:\/\/www.healthynewbornnetwork.org\/numbers\/\"><span style=\"font-style: italic;\">Newborn Numbers<\/span><\/a><span style=\"font-style: italic;\">\u00a0page and download the Excel spreadsheet to explore the data further.<\/span><\/h6>\r\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row full_width=\"stretch_row\" css=\".vc_custom_1452696349804{margin-top: 30px !important;margin-bottom: 30px !important;background-color: #f6f6f4 !important;}\"][vc_column][vc_text_separator title=\"More information\"][vc_column_text]Essential newborn care includes:\r\n<ul>\r\n \t<li>early initiation and exclusive breastfeeding<\/li>\r\n \t<li>thermal care (including prompt drying and covering at birth, maximizing skin-to-skin contact, delayed bathing, maintaining \u201cwarm chain\u201d)<\/li>\r\n \t<li>hygiene practices (including cord-care and caregiver handwashing)<\/li>\r\n<\/ul>\r\nThere is good evidence that adherence to these recommended practices substantially reduces mortality risk, especially for very small newborns. Health service contacts (notably associated with antenatal care and the hospital admission for childbirth) are important opportunities to influence these practices. In some settings, community health workers (CHWs) can serve as important channels to influence adoption of these practices among pregnant women.[\/vc_column_text][vc_text_separator title=\"Key Resources\"][vc_column_text]\r\n<ul>\r\n \t<li><a href=\"https:\/\/www.who.int\/tools\/essential-newborn-care-training-course\">Essential Newborn Care Course (WHO)<\/a>\u00a0\u2013 interim version of the second edition (2022)<\/li>\r\n \t<li><a href=\"https:\/\/www.aap.org\/en\/aap-global\/helping-babies-survive\/enc-now\/\" target=\"_blank\" rel=\"noopener\">ENC Now! (<\/a><a href=\"https:\/\/www.aap.org\/en\/aap-global\/helping-babies-survive\/enc-now\/\" target=\"_blank\" rel=\"noopener\">American Academy of Pediatrics (AAP) and Laerdal Global Health)<\/a><a href=\"https:\/\/www.aap.org\/en\/aap-global\/helping-babies-survive\/enc-now\/\" target=\"_blank\" rel=\"noopener\">\u00a0<\/a> \u2013 a digital version of the new WHO Essential Newborn Care 1 Basic Course (ENC) (formerly Helping Babies Breathe). (2022)<\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/no-harm-technical-briefs\/\" target=\"_blank\" rel=\"noopener\">Every Preemie\u2014SCALE: Do No Harm Technical Briefs<\/a> (2019)<\/li>\r\n \t<li><a href=\"http:\/\/www.who.int\/nutrition\/topics\/bfhi\/en\/\" target=\"_blank\" rel=\"noopener noreferrer\">Baby-friendly Hospital Initiative (WHO) <\/a>(2018)<\/li>\r\n<\/ul>\r\n[\/vc_column_text][\/vc_column][\/vc_row]","post_title":"Essential newborn care","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"essential-newborn-care","to_ping":"","pinged":"","post_modified":"2022-11-02 17:44:19","post_modified_gmt":"2022-11-02 21:44:19","post_content_filtered":"","post_parent":0,"guid":"http:\/\/www.healthynewbornnetwork.org\/?post_type=issue&#038;p=408","menu_order":0,"post_type":"issue","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":130,"post_author":"7211","post_date":"2015-10-21 15:20:03","post_date_gmt":"2015-10-21 15:20:03","post_content":"[vc_row full_width=\"stretch_row\" css=\".vc_custom_1453403441710{margin-top: -60px !important;padding-top: 30px !important;padding-bottom: 30px !important;background-color: #ffffff !important;}\"][vc_column width=\"1\/2\"][vc_column_text]\r\n<h2>It is crucial to use tested and standardized indicators for tracking and monitoring trends in neonatal health over time and making comparisons between districts, countries, or regions.<\/h2>\r\nUsing standard measurements should ensure collection of data that can be meaningfully analyzed and employed to inform program and policy decisions.[\/vc_column_text][\/vc_column][vc_column width=\"1\/2\" el_class=\"issue-stats\"][vc_row_inner content_placement=\"middle\"][vc_column_inner el_class=\"text-red\" width=\"1\/3\"][vc_column_text]\r\n<h1 style=\"text-align: center;\"><strong><span class=\"ticker\">10<\/span><\/strong><\/h1>\r\n[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\"2\/3\"][vc_column_text css=\".vc_custom_1666046459295{padding-top: 10px !important;padding-bottom: 10px !important;}\"]\r\n<h3 style=\"text-align: center;\"><span style=\"font-weight: 400;\">number of identified priority Every Newborn indicators<\/span><\/h3>\r\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_separator][vc_row_inner content_placement=\"middle\"][vc_column_inner el_class=\"text-yellow\" width=\"1\/3\"][vc_column_text]\r\n<h1 style=\"text-align: center;\"><strong><span class=\"ticker\">17<\/span><\/strong><\/h1>\r\n[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\"2\/3\"][vc_column_text css=\".vc_custom_1666046469073{padding-top: 10px !important;padding-bottom: 10px !important;}\"]\r\n<h3 style=\"text-align: center;\"><span style=\"font-weight: 400;\">number of Sustainable Development Goals<\/span><\/h3>\r\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_separator][vc_row_inner content_placement=\"middle\"][vc_column_inner][vc_column_text]\r\n<h6 style=\"text-align: center;\"><span style=\"font-style: italic;\">All data on this page represents the most recent data available, unless otherwise noted. Please visit our\u00a0<\/span><a href=\"https:\/\/www.healthynewbornnetwork.org\/numbers\/\"><span style=\"font-style: italic;\">Newborn Numbers<\/span><\/a><span style=\"font-style: italic;\">\u00a0page and download the Excel spreadsheet to explore the data further.<\/span><\/h6>\r\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_text_separator title=\"More information\"][vc_column_text]Several global bodies have developed recommended indicators for global tracking and use at country level. The <a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Every_Newborn_Action_Plan-ENGLISH_updated_July2014.pdf\" target=\"_blank\" rel=\"noopener\">Every Newborn Action Plan (ENAP)<\/a> has proposed a list of 10 core indicators and 10 additional indicators of impact and coverage of evidence-based newborn interventions. The World Health Organization (WHO) is compiling a list of core indicators aligned with the UN\u2019s <a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/the-global-strategy-for-womens-childrens-and-adolescents-health-2016-2030-survive-thrive-transform\/\" target=\"_blank\" rel=\"noopener\">Global Strategy for Women\u2019s, Children\u2019s, and Adolescents\u2019 Health<\/a>. This list has been informed by efforts to standardize indicators for the <a href=\"http:\/\/unstats.un.org\/sdgs\/\" target=\"_blank\" rel=\"noopener\">Sustainable Development Goals (SDGs)<\/a>, Ending Preventable Maternal Mortality (EPMM), ENAP, and the <a href=\"https:\/\/apps.who.int\/iris\/handle\/10665\/259951\" target=\"_blank\" rel=\"noopener\">WHO\u2019s Global Reference List of 100 Core Health Indicators<\/a>.\r\n\r\nEfforts are also underway to develop standardized indicators for monitoring the implementation strength and coverage of priority newborn health interventions:\r\n<ul>\r\n \t<li><strong>Kangaroo mother care (KMC)<\/strong>: The KMC Acceleration Partnership developed a measurement framework and 10 core indicators covering service readiness and service delivery.<\/li>\r\n \t<li><strong>Treatment of neonatal infections:<\/strong> Following the recent release of new WHO guidelines on managing possible severe bacterial infections in young infants when referral is not possible, WHO and implementing partners in early-adopter countries are currently working on a measurement framework with indicators. More information will be available soon.<\/li>\r\n \t<li><strong>Chlorhexidine for umbilical cord care<\/strong>: The global Chlorhexidine Working Group recommended indicators for inclusion in Demographic and Health Surveys (see information below on the new DHS optional newborn module) and is tracking indicators collected across countries.<\/li>\r\n<\/ul>\r\nBelow are descriptions and links to useful data collection tools, which include questions on newborn care. More information on mortality audits can be found on <a href=\"https:\/\/www.healthynewbornnetwork.org\/numbers\/\">this page<\/a>.[\/vc_column_text][vc_text_separator title=\"Household surveys\"][\/vc_column][\/vc_row][vc_row][vc_column width=\"1\/3\"][vc_column_text]\r\n<h4><a href=\"http:\/\/dhsprogram.com\/What-We-Do\/Survey-Types\/DHS-Questionnaires.cfm\" target=\"_blank\" rel=\"noopener\">Demographic and Health Surveys (DHS)<\/a><\/h4>\r\nUSAID-supported Demographic and Health Surveys (DHS) are nationally-representative household surveys that provide data for a wide range of monitoring and impact evaluation indicators in the areas of population, health, and nutrition. The DHS Phase 7 model women\u2019s questionnaire now includes questions on pre- and post-discharge contacts for newborns, the content of postnatal care for newborns, and newborn care practices. In addition, an optional newborn module is under development with additional questions on newborn care practices.[\/vc_column_text][\/vc_column][vc_column width=\"1\/3\"][vc_column_text]\r\n<h4><a href=\"https:\/\/mics.unicef.org\/\" target=\"_blank\" rel=\"noopener\">Multiple Indicator Cluster Surveys (MICS)<\/a><\/h4>\r\nUNICEF-supported Multiple Indicator Cluster Surveys (MICS) are nationally-representative household surveys that provide estimates of a range of indicators in the areas of health, education, child protection, and HIV\/AIDS. The MICS questionnaire now includes questions on the pre- and post-discharge postnatal contacts for mothers and newborns.[\/vc_column_text][\/vc_column][vc_column width=\"1\/3\"][vc_column_text]\r\n<h4><a href=\"https:\/\/www.mcsprogram.org\/resource\/knowledge-practice-coverage-tool\/\" target=\"_blank\" rel=\"noopener\">Knowledge Practices and Coverage Survey (KPC)<\/a><\/h4>\r\nThe Knowledge Practices and Coverage Survey (KPC) is a small population-based survey originally developed by Johns Hopkins University and used by grantees of USAID's Child Survival and Health Grants Program (CSHGP) since 1991. The KPC tool was revised to collect more data on newborn care practices.[\/vc_column_text][\/vc_column][\/vc_row][vc_row css=\".vc_custom_1456358177910{background-color: #ffffff !important;}\"][vc_column][vc_text_separator title=\"Health facility assessment tools\"][\/vc_column][\/vc_row][vc_row css=\".vc_custom_1456358191657{background-color: #ffffff !important;}\"][vc_column width=\"1\/2\"][vc_column_text]\r\n<h4><a href=\"https:\/\/www.who.int\/data\/data-collection-tools\/service-availability-and-readiness-assessment-(sara)?ua=1\" target=\"_blank\" rel=\"noopener\">Service Availability and Readiness Assessment (SARA)<\/a><\/h4>\r\nThe WHO-supported SARA is a health facility assessment tool designed to assess and monitor the service availability and readiness of the health sector and to generate evidence to support the planning and managing of a health system. It includes a section on service availability for maternal and newborn health.[\/vc_column_text][vc_column_text]\r\n<h4><a href=\"https:\/\/www.mchip.net\/qocsurveys\/\" target=\"_blank\" rel=\"noopener\">Maternal and Newborn Quality of Care Surveys<\/a><\/h4>\r\nThese health facility surveys, developed by the Maternal and Child Health Integrated Program (MCHIP), focus on the frequency and quality of interventions that address the direct causes of maternal and newborn deaths and can be key sources of information for policymakers and other stakeholders in country.[\/vc_column_text][\/vc_column][vc_column width=\"1\/2\"][vc_column_text]\r\n<h4><a href=\"http:\/\/dhsprogram.com\/What-We-Do\/Survey-Types\/SPA.cfm\" target=\"_blank\" rel=\"noopener\">Service Provision Assessment (SPA)<\/a><\/h4>\r\nThe USAID-supported SPA is a health facility assessment tool that provides a comprehensive overview of a country\u2019s health service delivery. It includes a section on delivery and newborn care in the inventory questionnaire, as well as additional questions related to services for newborns.[\/vc_column_text][vc_column_text]\r\n<h4><a href=\"https:\/\/www.mailman.columbia.edu\/research\/averting-maternal-death-and-disability-amdd\/toolkit\" target=\"_blank\" rel=\"noopener\">Emergency Obstetric and Neonatal Care Needs Assessment<\/a><\/h4>\r\nCreated by Averting Maternal Death and Disability (AMDD) at Columbia University, the\r\nEmergency Obstetric and Neonatal Care (EmONC) Needs Assessment is a health facility assessment tool that provides detailed data for planning to address gaps or problems in EmONC services. The tool is currently being revised to include more information on newborn services and quality of care.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=\"1\/3\"][\/vc_column][vc_column width=\"2\/3\"][vc_text_separator title=\"Other tools\"][\/vc_column][\/vc_row][vc_row][vc_column width=\"1\/3\"][vc_single_image image=\"13807\"][\/vc_column][vc_column width=\"1\/3\"][vc_column_text]\r\n<h4><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/saving-newborn-lives-tools-newborn-health-qualitative-research-improve-newborn-care-package\" target=\"_blank\" rel=\"noopener\">Guide to Qualitative Research to Improve Newborn Care Practices<\/a><\/h4>\r\nSave the Children\u2019s Guide to Qualitative Research to Improve Newborn Care Practices provides a reference tool for conducting qualitative (or formative) research and planning a behavior change communications strategy to improve newborn care practices.[\/vc_column_text][\/vc_column][vc_column width=\"1\/3\"][vc_column_text]\r\n<h4><a href=\"https:\/\/www.healthynewbornnetwork.org\/issue\/every-newborn\/\" target=\"_blank\" rel=\"noopener\">ENAP Tools<\/a><\/h4>\r\nENAP has also compiled <a href=\"https:\/\/www.healthynewbornnetwork.org\/issue\/every-newborn\/\" target=\"_blank\" rel=\"noopener\">an overview of tools<\/a> that can be used to sharpen existing reproductive, maternal, newborn, and child health (RMNCH) policies and plans, incorporating available evidence and data.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_text_separator title=\"Key resources\"][vc_column_text]\r\n<ul>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Every-Newborn-Metrics-Cards_3.pdf\" target=\"_blank\" rel=\"noopener\">Every Newborn Metrics Data Cards<\/a><\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/issue\/every-newborn\/\" target=\"_blank\" rel=\"noopener\">Every Newborn Tool Kit<\/a><\/li>\r\n \t<li><a href=\"http:\/\/journals.plos.org\/plosmedicine\/article?id=10.1371\/journal.pmed.1001340\" target=\"_blank\" rel=\"noopener\">New Signal Functions to Measure the Ability of Health Facilities to Provide Routine and Emergency Newborn Care<\/a><\/li>\r\n \t<li><a href=\"http:\/\/collections.plos.org\/measuring-coverage-in-mnch\" target=\"_blank\" rel=\"noopener\">Measuring Coverage in Maternal, Newborn, and Child Health<\/a><\/li>\r\n \t<li><a href=\"http:\/\/www.biomedcentral.com\/content\/pdf\/1471-2393-15-S2-S8.pdf\" target=\"_blank\" rel=\"noopener\">Count every newborn; a measurement improvement roadmap for coverage data<\/a><\/li>\r\n \t<li><a href=\"https:\/\/apps.who.int\/iris\/handle\/10665\/259951\" target=\"_blank\" rel=\"noopener\">Global Reference List of 100 Core Health Indicators, 2015<\/a><\/li>\r\n \t<li><a href=\"http:\/\/unstats.un.org\/sdgs\/\" target=\"_blank\" rel=\"noopener\">Sustainable Development Goal indicators<\/a><\/li>\r\n \t<li><a href=\"https:\/\/globalstrategy.everywomaneverychild.org\/\" target=\"_blank\" rel=\"noopener\">Global Strategy for Women's, Children's and Adolescent's Health 2016-2030<\/a><\/li>\r\n<\/ul>\r\n[\/vc_column_text][\/vc_column][vc_column][\/vc_column][vc_column][\/vc_column][\/vc_row]","post_title":"Monitoring & evaluation","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"monitoring-evaluation","to_ping":"","pinged":"","post_modified":"2022-10-20 16:44:30","post_modified_gmt":"2022-10-20 20:44:30","post_content_filtered":"","post_parent":0,"guid":"http:\/\/www.healthynewbornnetwork.org\/?post_type=issue&#038;p=130","menu_order":0,"post_type":"issue","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":134,"post_author":"7211","post_date":"2015-10-21 15:20:44","post_date_gmt":"2015-10-21 15:20:44","post_content":"[vc_row full_width=\"stretch_row\" css=\".vc_custom_1453403441710{margin-top: -60px !important;padding-top: 30px !important;padding-bottom: 30px !important;background-color: #ffffff !important;}\"][vc_column width=\"1\/2\"][vc_column_text]\r\n<h2>The first hours and days after birth are the riskiest for both mothers and newborns.<\/h2>\r\nThere are important interventions and practices during this period that can reduce these risks. There are also\u00a0opportunities at multiple points in time to help ensure high coverage for these interventions and practices. For example, contacts during pregnancy can be used for counseling and health education on newborn care and care-seeking for danger signs in the postnatal period. This support may be especially important in settings where births still take place at home.[\/vc_column_text][\/vc_column][vc_column width=\"1\/2\" el_class=\"issue-stats\"][vc_row_inner content_placement=\"middle\"][vc_column_inner el_class=\"text-red\" width=\"1\/3\"][vc_column_text]\r\n<h1 style=\"text-align: center;\"><strong><span class=\"ticker\">75<\/span><\/strong><\/h1>\r\n[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\"2\/3\"][vc_column_text css=\".vc_custom_1456333677270{padding-top: 10px !important;padding-bottom: 10px !important;}\"]\r\n<h3 style=\"text-align: center;\"><span style=\"font-weight: 400;\">percentage of newborn deaths that occur in the first week of life<\/span><\/h3>\r\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_separator][vc_row_inner content_placement=\"middle\"][vc_column_inner el_class=\"text-yellow\" width=\"1\/3\"][vc_column_text]\r\n<h1 style=\"text-align: center;\"><strong><span class=\"ticker\">48<\/span><\/strong><\/h1>\r\n[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\"2\/3\"][vc_column_text css=\".vc_custom_1456333713404{padding-top: 10px !important;padding-bottom: 10px !important;}\"]\r\n<h3 style=\"text-align: center;\"><span style=\"font-weight: 400;\">number of hours after birth when a newborn is at highest risk of death<\/span><\/h3>\r\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_separator][vc_row_inner content_placement=\"middle\"][vc_column_inner][vc_column_text]\r\n<h6 style=\"text-align: center;\"><span style=\"font-style: italic;\">All data on this page represents the most recent data available, unless otherwise noted. Please visit our\u00a0<\/span><a href=\"https:\/\/www.healthynewbornnetwork.org\/numbers\/\"><span style=\"font-style: italic;\">Newborn Numbers<\/span><\/a><span style=\"font-style: italic;\">\u00a0page and download the Excel spreadsheet to explore the data further.<\/span><\/h6>\r\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_text_separator title=\"More information\"][vc_column_text]Postnatal care can also include assessment and counseling provided to the mother before discharge after giving birth in a health facility, as well as later contacts during home visits by community health workers or postnatal visits to a health facility. Broadly, the major elements of postnatal care include:\r\n<ul>\r\n \t<li>counseling and health education on recognition of danger signs and appropriate care-seeking (for both mother and newborn)<\/li>\r\n \t<li>counseling and health education on routine care practices such as exclusive breastfeeding and good thermal care practices<\/li>\r\n \t<li>dispensing and related counseling for routine preventive interventions (such as chlorhexidine for cord-stump care and postnatal iron supplementation)<\/li>\r\n \t<li>assessment and case-management and referral for any identified complications or risk conditions<\/li>\r\n<\/ul>\r\nIt is through the same contacts that we have opportunities to improve outcomes for both mother and newborn, so programs and services\u00a0should focus on needed care for both. This more integrated perspective is reflected in the most recent guidance from\u00a0the World Health Organization\u00a0(see Resources below).\r\n\r\nHome visitation by community health workers has been promoted as a postnatal care strategy based on promising pilots in South Asia that demonstrated potential for reducing newborn deaths. However, it has proven difficult to achieve comparable benefits under more routine conditions at scale.\r\n\r\nWith the marked increases in institutional deliveries seen in many settings in recent years, there is increasing attention being given to taking better advantage of the time before discharge to ensure delivery of key aspects of postnatal care. Challenges to taking optimal advantage of this contact include the very high volume of births in some centers and the common practice of early discharge.\r\n\r\nFollow-up visits to the health facility for postnatal care can provide an important opportunity to ensure assessment, care, and provision of important counseling. Suitable timing and content of such care will depend on the overall configuration of postnatal care services specific to the setting.[\/vc_column_text][vc_text_separator title=\"Key Resources\"][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]\r\n<ul>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/who-recommendations-on-maternal-and-newborn-care-for-a-positive-postnatal-experience\/\">WHO recommendations on maternal and newborn care for a positive postnatal experience (2022)<\/a><\/li>\r\n<\/ul>\r\n[\/vc_column_text][\/vc_column][\/vc_row]","post_title":"Postnatal care","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"postnatal-care","to_ping":"","pinged":"","post_modified":"2022-10-17 18:49:11","post_modified_gmt":"2022-10-17 22:49:11","post_content_filtered":"","post_parent":0,"guid":"http:\/\/www.healthynewbornnetwork.org\/?post_type=issue&#038;p=134","menu_order":0,"post_type":"issue","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":135,"post_author":"7211","post_date":"2015-10-21 15:20:52","post_date_gmt":"2015-10-21 15:20:52","post_content":"[vc_row full_width=\"stretch_row\" css=\".vc_custom_1453403441710{margin-top: -60px !important;padding-top: 30px !important;padding-bottom: 30px !important;background-color: #ffffff !important;}\"][vc_column width=\"1\/2\"][vc_column_text]\r\n<h2>Many countries, even those that have achieved improvements in the last 15 years, still experience high rates of maternal and newborn deaths due to poor quality services.<\/h2>\r\nPoor quality can affect the demand for care from communities. Accelerating reduction of preventable deaths and poor outcomes depends on service quality improvements, including addressing health system challenges such as infrastructure, supplies, skilled and appropriately deployed health providers, and management. Quality improvement systems that address both the content and standards as well as the process and experience of care should be an important area of investment during the period of the new <a href=\"http:\/\/www.un.org\/sustainabledevelopment\/sustainable-development-goals\/\" target=\"_blank\">Sustainable Development Goals<\/a>.[\/vc_column_text][\/vc_column][vc_column width=\"1\/2\" el_class=\"issue-stats\"][vc_single_image image=\"13784\"][vc_separator][vc_row_inner content_placement=\"middle\"][vc_column_inner][vc_empty_space height=\"16px\"][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]","post_title":"Quality improvement","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"quality-improvement","to_ping":"","pinged":"","post_modified":"2016-02-25 15:58:05","post_modified_gmt":"2016-02-25 20:58:05","post_content_filtered":"","post_parent":0,"guid":"http:\/\/www.healthynewbornnetwork.org\/?post_type=issue&#038;p=135","menu_order":0,"post_type":"issue","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":323,"post_author":"7211","post_date":"2016-01-12 17:55:54","post_date_gmt":"2016-01-12 17:55:54","post_content":"<p>[vc_row full_width=\"stretch_row\" css=\".vc_custom_1453922923730{margin-top: -60px !important;padding-top: 30px !important;padding-bottom: 30px !important;background-color: #ffffff !important;}\"][vc_column width=\"1\/2\"][vc_column_text]<\/p>\n<h2>As reflected in Millennium Development Goals 4 and 5 and now the Sustainable Development Goals, our objective is to <strong>reduce the global burden of preventable deaths<\/strong>.<\/h2>\n<p>In the case of newborn work, we focus particularly on stillbirths, maternal deaths, and newborn deaths. Meeting our objectives at the level of whole populations requires that we do much better in ensuring that the highest proportion possible adopt key practices and receive specific interventions. We need <strong>high effective coverage at scale<\/strong> for key behaviors and specific high-impact elements of care. While \u201cscaling-up\u201d may be part of how we achieve sustained impact at scale, we must guard against scale-up as an end in itself. It is easy to fall into the \u201cempty scale-up\u201d trap.[\/vc_column_text][\/vc_column][vc_column width=\"1\/2\" el_class=\"issue-stats\"][vc_row_inner content_placement=\"middle\"][vc_column_inner el_class=\"text-red\" width=\"1\/3\"][vc_column_text]<\/p>\n<h1 style=\"text-align: center;\"><strong><span class=\"ticker\">287<\/span>k<\/strong><\/h1>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\"2\/3\"][vc_column_text css=\".vc_custom_1690998058971{padding-top: 10px !important;padding-bottom: 10px !important;}\"]<\/p>\n<h3 style=\"text-align: center;\"><span style=\"font-weight: 400;\">number of women who died due to pregnancy or childbirth-related complications in 2020<br \/>\n<\/span><\/h3>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_separator][vc_row_inner content_placement=\"middle\"][vc_column_inner el_class=\"text-yellow\" width=\"1\/3\"][vc_column_text]<\/p>\n<h1 style=\"text-align: center;\"><strong><span class=\"ticker\">5<\/span>m<\/strong><\/h1>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\"2\/3\"][vc_column_text css=\".vc_custom_1651603452364{padding-top: 10px !important;padding-bottom: 10px !important;}\"]<\/p>\n<h3 style=\"text-align: center;\"><span style=\"font-weight: 400;\">number of children under age 5 who died in 2020<\/span><\/h3>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_separator][vc_row_inner content_placement=\"middle\"][vc_column_inner el_class=\"text-blue\" width=\"1\/3\"][vc_column_text]<\/p>\n<h1 style=\"text-align: center;\"><strong><span class=\"ticker\">47<\/span><\/strong><\/h1>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\"2\/3\"][vc_column_text css=\".vc_custom_1651603474028{padding-top: 10px !important;padding-bottom: 10px !important;}\"]<\/p>\n<h3 style=\"text-align: center;\"><span style=\"font-weight: 400;\">percentage of all under-5 deaths that occurred during the first 28 days of life in 2020<\/span><\/h3>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_separator][vc_column_text]<\/p>\n<h6 style=\"text-align: center;\"><em>All data on this page represents the most recent data available, unless otherwise noted. Please visit our <a href=\"https:\/\/www.healthynewbornnetwork.org\/numbers\/\">Newborn Numbers<\/a> page and download the Excel spreadsheet to explore the data further.<\/em><\/h6>\n<p>[\/vc_column_text][vc_row_inner content_placement=\"middle\"][vc_column_inner][vc_empty_space][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_text_separator title=\"More information\"][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]Where effective coverage is low, program efforts need to contribute to increasing and sustaining improved coverage. In some instances the interventions are already available and in use but at low effective coverage. In these cases improved delivery is needed \u2013 which may entail strengthened implementation or new delivery strategies. In situations where effective interventions are novel and not yet widely introduced, these methods may require some kind of scaling-up process to increase coverage. Because there are important differences between settings, a specific strategy or package will not be the answer for all settings.[\/vc_column_text][vc_column_text]<strong>Key resources<\/strong>:<\/p>\n<ul>\n<li><a href=\"http:\/\/www.expandnet.net\/tools.htm\" target=\"_blank\" rel=\"noopener noreferrer\">Expandnet scale-up resources<\/a><\/li>\n<li><a href=\"https:\/\/www.msiworldwide.com\/sites\/default\/files\/additional-resources\/2018-11\/ScalingUp_3rdEdition.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Scaling Up\u2014From Vision to Large-scale Change: A Management Framework for Practitioners<\/a><\/li>\n<li><a href=\"http:\/\/implementationscience.biomedcentral.com\/articles\/10.1186\/s13012-016-0374-x\" target=\"_blank\" rel=\"noopener noreferrer\">A framework for scaling up health interventions: lessons from large-scale improvement initiatives in Africa.<\/a><\/li>\n<li><a href=\"http:\/\/www.mcsprogram.org\/resources\/lessons-learned-from-the-scale-up-experience-of-six-high-impact-interventions-in-reproductive-maternal-newborn-and-child-health\/\" target=\"_blank\" rel=\"noopener noreferrer\">Lessons Learned from the Scale-Up Experience of Six High-Impact Interventions in Reproductive, Maternal, Newborn, and Child Health<\/a><\/li>\n<\/ul>\n<p>[\/vc_column_text][vc_column_text]<strong>Related\u00a0resources<\/strong>:<\/p>\n<ul>\n<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Empty-Scale-up-Meeting-Report.pdf\">Empty Scale-Up Meeting Report<\/a><\/li>\n<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/hnn-content\/uploads\/Empty-Scale-Up-Working-Paper_Dec2016.pdf\">Empty Scale-Up\u00a0Draft Working Paper<\/a><\/li>\n<\/ul>\n<p>[\/vc_column_text][vc_row_inner][vc_column_inner][vc_btn title=\"Scaling Up Substance Working Group\" color=\"1\" link=\"url:https%3A%2F%2Fwww.healthynewbornnetwork.org%2Fworking-group%2Fscaling-up-substance%2F||\"][vc_column_text]<\/p>\n<h3>Note: This working group is for members only. If you are a member on HNN, please log in <a href=\"https:\/\/www.healthynewbornnetwork.org\/login\/\">here<\/a> and email <strong><a href=\"mailto:info@healthynewbornnetwork.org\">info@healthynewbornnetwork.org<\/a> <\/strong>to join this working group. If you are not a member, please register <a href=\"https:\/\/www.healthynewbornnetwork.org\/join-the-network\/\">here<\/a> and tell us in your short bio that you\u2019d like to join this working group.<\/h3>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n","post_title":"Scale-up","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"scale-up","to_ping":"","pinged":"","post_modified":"2023-08-02 13:42:00","post_modified_gmt":"2023-08-02 17:42:00","post_content_filtered":"","post_parent":0,"guid":"http:\/\/www.healthynewbornnetwork.org\/?post_type=issue&#038;p=323","menu_order":0,"post_type":"issue","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":55231,"post_author":"7211","post_date":"2022-09-20 15:41:44","post_date_gmt":"2022-09-20 19:41:44","post_content":"[vc_row full_width=\"stretch_row\" css=\".vc_custom_1663702110176{margin-top: -60px !important;padding-top: 30px !important;padding-bottom: 30px !important;background-color: #ffffff !important;}\"][vc_column width=\"1\/2\"][vc_column_text]\r\n<h2 style=\"text-align: justify;\">Ensuring optimal umbilical cord care at birth and during the first week of life is a crucial strategy to prevent life-threatening sepsis and cord infections and avert preventable neonatal deaths.<\/h2>\r\nThe World Health Organization (WHO) <a href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240045989\">recommends<\/a> clean, dry umbilical cord care for all newborns, including those born in facilities, at home, and in humanitarian settings. Proper cord care includes using clean, sterile blades and ties, keeping the stump clean using soap and water, and drying thoroughly with a clean cloth after getting wet. In most settings, proper clean, dry umbilical cord care is sufficient to prevent infection.\r\n\r\nHowever, in settings where harmful traditional substances are placed on the cord, WHO recommends using chlorhexidine digluconate in addition to clean, dry cord care. Chlorhexidine digluconate (CHX) is a broad-spectrum antiseptic that is available in a range of concentrations, and has been safely used for over 40 years for a variety of health-related applications. Its specific use for umbilical cord care was originally tested in three clinical trials in Nepal, Bangladesh, and Pakistan, in the form of 4% chlorhexidine, delivered through a 7.1% chlorhexidine digluconate gel. In 2013 the WHO added CHX to its\u00a0<a href=\"http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/\">Model List of Essential Medicines<\/a>; and in 2014 the WHO issued <a href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/97603\/1\/9789241506649_eng.pdf?ua=1\">guidelines<\/a>\u00a0on umbilical cord care, which included a formal recommendation on the use of chlorhexidine. This guidance was subsequently <a href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240045989\">updated<\/a> in 2022, reflecting the current recommendation for CHX use in certain settings.\r\n\r\nCHX is the primary recommendation for settings where harmful traditional substances, such as oils, compresses, native plants, or other organic substances, are commonly placed on the umbilical cord. It was previously recommended for settings with high rates of home birth and neonatal mortality, where mothers, traditional birth attendants, and community health workers can be trained to administer CHX; as a result, this may be included as a recommendation in some national protocols.\r\n\r\nIn humanitarian settings, clean and dry umbilical cord care is the standard, but the use of chlorhexidine digluconate is also included as a recommendation in the <a href=\"https:\/\/iawgfieldmanual.com\/manual\">Inter-Agency Field Manual for Reproductive Health in Humanitarian Settings (IAFM),<\/a> the gold-standard for sexual and reproductive care in fragile and humanitarian settings. The IAFM includes CHX for cord care as a recommendation during the onset of emergencies, as part of the <a href=\"https:\/\/iawgfieldmanual.com\/manual\/misp\">Minimum Initial Service Package<\/a> (MISP), and as part of comprehensive maternal and newborn health (MNH) services. Additionally, chlorhexidine digluconate is included as a supplementary commodity in the <a href=\"https:\/\/www.unfpa.org\/sites\/default\/files\/resource-pdf\/IARH-Kits-6th-Edition_Manual_English.pdf\">Inter-Agency Reproductive Health Kits<\/a> (RH Kits), which provide the supplies necessary to implement the MISP at the onset of a humanitarian response.[\/vc_column_text][\/vc_column][vc_column width=\"1\/2\" el_class=\"issue-stats\"][vc_empty_space][vc_row_inner content_placement=\"middle\"][vc_column_inner el_class=\"text-red\" width=\"1\/4\"][vc_column_text]\r\n<h1 style=\"text-align: center;\"><strong><span class=\"ticker\">2.4<\/span>m<\/strong><\/h1>\r\n[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\"3\/4\"][vc_column_text css=\".vc_custom_1666120145784{padding-top: 10px !important;padding-bottom: 10px !important;}\"]\r\n<h3 style=\"text-align: center;\"><span style=\"font-weight: 400;\">newborn deaths worldwide in 2020<\/span><\/h3>\r\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_separator][vc_row_inner content_placement=\"middle\"][vc_column_inner el_class=\"text-yellow\" width=\"1\/4\"][vc_column_text]\r\n<h1 style=\"text-align: center;\"><strong><span class=\"ticker\">7<\/span><\/strong><\/h1>\r\n[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\"3\/4\"][vc_column_text css=\".vc_custom_1666120079406{padding-top: 10px !important;padding-bottom: 10px !important;}\"]\r\n<h3 style=\"text-align: center;\"><span style=\"font-weight: 400;\">percent of deaths caused by sepsis and other infectious conditions of the newborn in 2020<\/span><\/h3>\r\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_separator][vc_column_text]\r\n<h6 style=\"text-align: center;\"><em>All data on this page represents the most recent data available, unless otherwise noted. Please visit our <a href=\"https:\/\/www.healthynewbornnetwork.org\/numbers\/\">Newborn Numbers<\/a> page and download the Excel spreadsheet to explore the data further.\u00a0<\/em><\/h6>\r\n[\/vc_column_text][vc_separator][vc_empty_space][vc_cta h2=\"Cautionary note\"]\r\n<h3 style=\"text-align: justify; line-height: 13.5pt; background: #F7F7F7; margin: 0in 0in 18.75pt 0in;\"><strong><span style=\"font-size: 10.0pt; font-family: 'Arial',sans-serif; color: #333333;\">As with all medications, care must be taken to ensure that the product is used appropriately. 7.1% chlorhexidine digluconate for umbilical cord care should be kept out of eyes and ears and should be applied only to the umbilical stump.<\/span><\/strong><b><\/b><\/h3>\r\n<h3 style=\"text-align: justify; line-height: 13.5pt; background: #F7F7F7; margin: 0in 0in 18.75pt 0in;\"><b><span style=\"font-size: 10.0pt; font-family: 'Arial',sans-serif; color: #333333;\">Since 2015, there have been over <\/span><\/b><a href=\"https:\/\/www.who.int\/news\/item\/28-08-2020-chlorhexidine-7-1-digluconate-(chx)-aqueous-solution-or-gel-(10ml)-reports-of-serious-eye-injury-due-to-errors-in-administration\"><span style=\"font-size: 10.0pt; font-family: 'Arial',sans-serif;\">40 reported cases<\/span><\/a><b><span style=\"font-size: 10.0pt; font-family: 'Arial',sans-serif; color: #333333;\"> of incorrect administration of CHX in nine countries in sub Saharan Africa, specifically when CHX in both liquid and gel form have been mistaken for eye medication. In these reported cases, 7.1% chlorhexidine digluconate in both liquid and gel forms for umbilical cord care was mistakenly applied to the eyes, causing eye injury.\u00a0\u00a0 Chlorhexidine has been in use for over 40 years and has a well\u2013characterized safety profile when used as directed. The formulation of chlorhexidine digluconate used for cord care (7.1% w\/v), when used as directed, is effective in preventing neonatal sepsis due to bacterial exposure through the fresh umbilical stump. \u00a0However, it can cause serious harm if applied to the eyes and should also not be put into the ear canal. It is important that persons and organizations responsible for chlorhexidine for umbilical cord care programs and for the distribution of the chlorhexidine for umbilical cord care product to caregivers ensure that instruction is provided on the appropriate use of the product, including appropriate warnings.<\/span><\/b><\/h3>\r\n<h3 style=\"line-height: 13.5pt; background: #F7F7F7; margin: 0in 0in 18.75pt 0in;\"><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/memorandum-safety-concerns-over-misuse-of-chlorhexidine-chx\/\"><span style=\"font-size: 10.0pt; font-family: 'Arial',sans-serif; color: #e05533;\">Memorandum: Safety Concerns Over Misuse of Chlorhexidine (CHX)<\/span><\/a><b><\/b><\/h3>\r\n<h3 style=\"margin-top: 0in; line-height: 13.5pt; background: #F7F7F7;\"><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/alert-no-133-chlorhexidine-71-digluconate-chx-reports-of-serious-eye-injury-due-to-errors-in-administration\/\"><span style=\"font-size: 10.0pt; font-family: 'Arial',sans-serif; color: #e05533;\">Alert No. 133: Chlorhexidine 7,1% digluconate (CHX): Reports of serious eye injury due to errors in administration<\/span><\/a><b><\/b><\/h3>\r\n[\/vc_cta][\/vc_column][\/vc_row][vc_row][vc_column][vc_text_separator title=\"Key Resources\"][vc_column_text]\r\n<ul>\r\n \t<li><a href=\"https:\/\/globalhealthmedia.org\/videos\/care-of-the-cord\/\">Video on proper cord care for practitioners (2015)<\/a><\/li>\r\n \t<li><a href=\"https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2021.02\">WHO Model List of Essential Medicines (22nd list, 2021)<\/a><\/li>\r\n \t<li><a href=\"https:\/\/savechildrenusa-my.sharepoint.com\/personal\/hwartinger_savechildren_org\/Documents\/HNN\/Page%20Drafts\/who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2021.03\">WHO Model List of Essential Medicines for Children (8<sup>th<\/sup> list, 2021)<\/a><\/li>\r\n \t<li><a href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240045989\">WHO recommendations on maternal and newborn care for a positive postnatal experience (2022)<\/a><\/li>\r\n \t<li><a href=\"https:\/\/iawgfieldmanual.com\/manual\">Inter-Agency Field Manual for Reproductive Health in Humanitarian Settings (2018)<\/a><\/li>\r\n \t<li><a href=\"https:\/\/iawgfieldmanual.com\/manual\/misp\">Minimum Initial Service Package (2018)<\/a><\/li>\r\n \t<li><a href=\"https:\/\/www.unfpa.org\/sites\/default\/files\/resource-pdf\/IARH-Kits-6th-Edition_Manual_English.pdf\">Inter-Agency Reproductive Health Kits<\/a><\/li>\r\n \t<li><a href=\"https:\/\/www.who.int\/news\/item\/28-08-2020-chlorhexidine-7-1-digluconate-(chx)-aqueous-solution-or-gel-(10ml)-reports-of-serious-eye-injury-due-to-errors-in-administration\">Chlorhexidine 7,1% digluconate (CHX) aqueous solution or gel (10ml): Reports of serious eye injury due to errors in administration (2020)<\/a><\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/memorandum-safety-concerns-over-misuse-of-chlorhexidine-chx\/\">Memorandum: Safety Concerns Over Misuse of Chlorhexidine (CHX) (2019)<\/a><\/li>\r\n \t<li><a href=\"https:\/\/www.healthynewbornnetwork.org\/resource\/alert-no-133-chlorhexidine-71-digluconate-chx-reports-of-serious-eye-injury-due-to-errors-in-administration\/\">Alert No. 133: Chlorhexidine 7,1% digluconate (CHX): Reports of serious eye injury due to errors in administration (2019)<\/a><\/li>\r\n<\/ul>\r\n[\/vc_column_text][\/vc_column][\/vc_row]","post_title":"Umbilical cord care","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"umbilical-cord-care","to_ping":"","pinged":"","post_modified":"2022-12-27 14:18:49","post_modified_gmt":"2022-12-27 19:18:49","post_content_filtered":"","post_parent":0,"guid":"https:\/\/www.healthynewbornnetwork.org\/?post_type=issue&#038;p=55231","menu_order":0,"post_type":"issue","post_mime_type":"","comment_count":"0","filter":"raw"}],"regions":[],"countries":[],"views":"906","ft_img_caption":""},"_links":{"self":[{"href":"https:\/\/www.healthynewbornnetwork.org\/wp-json\/wp\/v2\/resource\/18014"}],"collection":[{"href":"https:\/\/www.healthynewbornnetwork.org\/wp-json\/wp\/v2\/resource"}],"about":[{"href":"https:\/\/www.healthynewbornnetwork.org\/wp-json\/wp\/v2\/types\/resource"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthynewbornnetwork.org\/wp-json\/wp\/v2\/users\/7211"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthynewbornnetwork.org\/wp-json\/wp\/v2\/comments?post=18014"}],"version-history":[{"count":0,"href":"https:\/\/www.healthynewbornnetwork.org\/wp-json\/wp\/v2\/resource\/18014\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.healthynewbornnetwork.org\/wp-json\/wp\/v2\/media\/18016"}],"wp:attachment":[{"href":"https:\/\/www.healthynewbornnetwork.org\/wp-json\/wp\/v2\/media?parent=18014"}],"wp:term":[{"taxonomy":"toolkit","embeddable":true,"href":"https:\/\/www.healthynewbornnetwork.org\/wp-json\/wp\/v2\/toolkit?post=18014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}